factor

(redirected from procoagulant factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
For some women, however, the changes in the procoagulant factors may persist for at least 7 to 10 days postpartum.
[5] The most significant hematological changes are physiologic anemia, neutrophilia, mild thrombocytopenia, increased procoagulant factors, and diminished fibrinolysis.
The first, represented by the procoagulant factors, is triggered by tissue factor (TF), (3) a cellular receptor in damaged tissues that forms a complex with activated factor VII (FVIIa) at the site of injury (Fig.
Because transdermal menopausal estrogen therapy does not increase hepatic production of procoagulant factors, as does oral estrogen, it is biologically plausible that transdermal therapy is safer than oral therapy in terms of the risk of VTE.
The PT and APTT have been surmised from their design to be sensitive to the procoagulant factors but to be much less sensitive to the anticoagulant factors (11).
The development of the placental circulation is crucial to the establishment of pregnancy and is ensured by structural modifications of the spiral arteries (25) and establishment of a hypercoagulable state from an increase in procoagulant factors and a decrease in anticoagulant factors and fibrinolysis (26).
Thus, the clotting time of the plasma from anticoagulated patients, recorded in a PT assay, results from two opposing reactions: the reduction in the activity of the procoagulant factors (VII, X, II, and IX) balanced by the reduction of the anticoagulant factors (proteins C and 5).